Skip to results
Modify your search
NARROW
1-20 of 28
Authors: Genevieve Chene
Sort by
Journal Article
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2) Open Access
Sophie Matheron and others
Clinical Infectious Diseases, Volume 67, Issue 8, 15 October 2018, Pages 1161–1167, https://doi.org/10.1093/cid/ciy245
Published: 24 March 2018
Journal Article
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia Free
The Pediatric AIDS-Defining Cancer Project Working Group for IeDEA Southern Africa, TApHOD, and COHERE in EuroCoord and others
Clinical Infectious Diseases, Volume 63, Issue 9, 1 November 2016, Pages 1245–1253, https://doi.org/10.1093/cid/ciw519
Published: 30 August 2016
Journal Article
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study Open Access
Margaret T. May and others
Clinical Infectious Diseases, Volume 62, Issue 12, 15 June 2016, Pages 1571–1577, https://doi.org/10.1093/cid/ciw183
Published: 29 March 2016
Journal Article
Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery
Get access
Frederik N. Engsig and others
Clinical Infectious Diseases, Volume 58, Issue 9, 1 May 2014, Pages 1312–1321, https://doi.org/10.1093/cid/ciu038
Published: 22 January 2014
Journal Article
The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era
Get access
A. Mocroft and others
Clinical Infectious Diseases, Volume 57, Issue 7, 1 October 2013, Pages 1038–1047, https://doi.org/10.1093/cid/cit423
Published: 06 August 2013
Journal Article
Predictors of CD4+ T-Cell Counts of HIV Type 1–Infected Persons After Virologic Failure of All 3 Original Antiretroviral Drug Classes
Get access
The Pursuing Later Treatment Option II (PLATO II) Project Team of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) and others
The Journal of Infectious Diseases, Volume 207, Issue 5, 1 March 2013, Pages 759–767, https://doi.org/10.1093/infdis/jis752
Published: 07 December 2012
Journal Article
Impact of HIV-1 Subtype on CD4 Count at HIV Seroconversion, Rate of Decline, and Viral Load Set Point in European Seroconverter Cohorts
Get access
Giota Touloumi and others
Clinical Infectious Diseases, Volume 56, Issue 6, 15 March 2013, Pages 888–897, https://doi.org/10.1093/cid/cis1000
Published: 07 December 2012
Journal Article
Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression
Get access
Rodolphe Thiébaut and others
Clinical Infectious Diseases, Volume 55, Issue 10, 15 November 2012, Pages 1417–1425, https://doi.org/10.1093/cid/cis708
Published: 20 August 2012
Journal Article
Immunovirological Response to Triple Nucleotide Reverse-Transcriptase Inhibitors and Ritonavir-Boosted Protease Inhibitors in Treatment-Naive HIV-2–Infected Patients: The ACHIEV2E Collaboration Study Group
Get access
Antoine Benard and others
Clinical Infectious Diseases, Volume 52, Issue 10, 15 May 2011, Pages 1257–1266, https://doi.org/10.1093/cid/cir123
Published: 15 May 2011
Journal Article
Long-Term Evolution and Determinants of Renal Function in HIV-Infected Patients Who Began Receiving Combination Antiretroviral Therapy in 1997–1999, ANRS CO8 APROCO-COPILOTE
Get access
Catherine Leport and others
Clinical Infectious Diseases, Volume 49, Issue 12, 15 December 2009, Pages 1950–1954, https://doi.org/10.1086/648445
Published: 15 December 2009
Journal Article
Role of Uncontrolled HIV RNA Level and Immunodeficiency in the Occurrence of Malignancy in HIV-Infected Patients during the Combination Antiretroviral Therapy Era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort
Get access
Mathias Bruyand and others
Clinical Infectious Diseases, Volume 49, Issue 7, 1 October 2009, Pages 1109–1116, https://doi.org/10.1086/605594
Published: 01 October 2009
Journal Article
Changes in Cancer Mortality among HIV-Infected Patients: The Mortalité 2005 Survey
Get access
Fabrice Bonnet and others
Clinical Infectious Diseases, Volume 48, Issue 5, 1 March 2009, Pages 633–639, https://doi.org/10.1086/596766
Published: 01 March 2009
Journal Article
Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099
Get access
Valérie Journot and others
Clinical Infectious Diseases, Volume 42, Issue 12, 15 June 2006, Pages 1790–1799, https://doi.org/10.1086/504323
Published: 15 June 2006
Journal Article
Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor—Containing Therapy
Get access
Xavier Duval and others
Clinical Infectious Diseases, Volume 39, Issue 2, 15 July 2004, Pages 248–255, https://doi.org/10.1086/422141
Published: 15 July 2004
Journal Article
Risk Factors for Coronary Heart Disease in Patients Treated for Human Immunodeficiency Virus Infection Compared with the General Population
Get access
Marianne Savès and others
Clinical Infectious Diseases, Volume 37, Issue 2, 15 July 2003, Pages 292–298, https://doi.org/10.1086/375844
Published: 15 July 2003
Journal Article
Comparison of 2 Regimens that Include Interferon-α-2a plus Ribavirin for Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus—Coinfected Patients
Get access
Didier Neau and others
Clinical Infectious Diseases, Volume 36, Issue 12, 15 June 2003, Pages 1564–1571, https://doi.org/10.1086/375067
Published: 15 June 2003
Journal Article
Interferon-Ribavirin in Association with Stavudine Has No Impact on Plasma Human Immunodeficiency Virus (HIV) Type 1 Level in Patients Coinfected with HIV and Hepatitis C Virus: A CORIST-ANRS HC1 Trial
Get access
Dominique Salmon-Céron and others
Clinical Infectious Diseases, Volume 36, Issue 10, 15 May 2003, Pages 1295–1304, https://doi.org/10.1086/374837
Published: 15 May 2003
Journal Article
Mechanisms of Early Virologic Failure in Antiretroviral-Naive Patients Starting Protease Inhibitor–Containing Regimens: The APROVIR Study
Get access
Bernard Masquelier and others
The Journal of Infectious Diseases, Volume 186, Issue 10, 15 November 2002, Pages 1503–1507, https://doi.org/10.1086/344358
Published: 15 November 2002
Journal Article
Factors Associated with Mortality in Human Immunodeficiency Virus Type 1–Infected Adults Initiating Protease Inhibitor–Containing Therapy: Role of Education Level and of Early Transaminase Level Elevation (APROCO–ANRS EP11 Study)
Get access
Charlotte Lewden and others
The Journal of Infectious Diseases, Volume 186, Issue 5, 1 September 2002, Pages 710–714, https://doi.org/10.1086/342047
Published: 01 September 2002
Journal Article
Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus—Infected Patients
Get access
Geneviève Chêne and others
Clinical Infectious Diseases, Volume 34, Issue 5, 1 March 2002, Pages 649–657, https://doi.org/10.1086/338811
Published: 01 March 2002